JPRN-jRCTs031210101
Completed
N/A
Multicenter prospective registration and intervention studies for chemotherapy-induced peripheral neuropathy - MiroCIP Study
Kuwabara Satoshi0 sites275 target enrollmentMay 20, 2021
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- chemotherapy-induced peripheral neuropathy
- Sponsor
- Kuwabara Satoshi
- Enrollment
- 275
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Registry study
- •(1\) Patients aged 20 years or older at informed consent
- •(2\) The following cancer patients who are scheduled to have chemotherapy with Oxaliplatin or Taxane anticancer drugs within 14 days after the enrollment
- •\-Colorectal cancer (scheduled to be treated according to regimens including Oxaliplatin)
- •\-Gastric cancer (scheduled to be treated according to regimens including Oxaliplatin or Taxane anticancer drugs)
- •\-Non\-small cell lung cancer (scheduled to be treated according to regimens including Taxane anticancer drugs)
- •\-Breast cancer (scheduled to be treated according to regimens including Taxane anticancer drugs)
- •(3\) Patients who have voluntarily agreed in writing to participate in this study after receiving sufficient explanations from their study doctors and adequately understanding this study
- •Interventional study
- •(1\) Patients aged 20 years or older at informed consent
Exclusion Criteria
- •Registry study
- •(1\) Patients who have severe diabetes \[HbA1c (NGSP) \> 8\.4%]
- •(2\) Patients who have alcohol polydipsia history or alcoholism
- •(3\) Patients who have severe cervical or lumbar spondylosis
- •(4\) Patients with poor prognosis
- •(5\) Patients whose CIPN\-induced pains are difficult to be assessed due to the pains caused by the other diseases or factors
- •(6\) Patients who are considered inappropriate for this study by Principal investigators or Sub investigators
- •Interventional study
- •(1\) Patients whose CIPN\-induced pains are difficult to be assessed due to the pains caused by the other diseases or factors
- •(2\) Pregnant, possibly pregnant, or lactating patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Multicenter Prospective registration research for pain relief after EUS-guided neurolysis in patients suffering from upper abdominal cancer pain caused by pancreatic cancerPancreatic cancerJPRN-UMIN000031228Kindai University Faculty of Medicine50
Not Yet Recruiting
N/A
Multicenter prospective registration study evaluating diagnostic yield of the 22G Franseen needle in patients undergoing EUS-guided tissue acquisition of pancreatic solid lesionsJPRN-UMIN000033530Tokyo University235
Completed
N/A
An Observational prospective Multicenter registry study on Outcomes of peripheral arTErial disease patieNts treated by AngioplaSty tHerapy in aortoIliac arteryPeripheral artery diseaseJPRN-UMIN000013849Research group on endovascular treatment in aortiliac artery1,500
Recruiting
N/A
Prospective registry trial of trans-arterial embolization for dural arteriovenous fistula using PHIdural arteriovenous fistulaJPRN-UMIN000038325Kobe City Medical Center General Hospital22
Recruiting
N/A
Prospective registry trial of pre-surgical embolization for brain arteriovenous malformation using PHIbrain arteriovenous malformationJPRN-UMIN000038303Kobe City Medical Center General Hospital40